BR Waterfull BB BLEMISH BALM BRIGHT

Manufacturer
BR
Effective date
2016-04-18
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:45:43

Label at a glance#

ProductBR Waterfull BB BLEMISH BALM BRIGHT
Active ingredientTitanium Dioxide, Octinoxate
Label structure6 sections

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient: Titanium Dioxide 7.0%, Ethylhexyl Methoxycinnamate 1.5%

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

Inactive Ingredients: Water, Caprylic/Capric Triglyceride, Glycerin, Propylene Glycol, Petrolatum, Cetyl Ethylhexanoate, Cyclopentasiloxane, Cyclohexasiloxane, Cetyl PEG/PPG-10/1Dimethicone, Dimethicone, Beeswax, Centella Asiatica Extract, Aloe Barbadensis Leaf Juice, Biosaccharide Gum-1, Trehalose, Panthenol, Sodium hyaluronate, Sodium Chloride, Sorbitan Sesquioleate, Lavandula Angustifolia (Lavender) Flower Extract, Monarda Didyma Leaf Extract, Mentha Piperita (Peppermint) Leaf Extract, Freesia Refracta Extract, Chamomilla Recutita(Matricaria) Flower Extract, Rosmarinus Officinalis (Rosemary) Leaf Extract, Paeonia Suffruticosa Root Extract, Scutellaria Baicalensis Root Extract, Butylene Glycol, Caprylhydroxamic Acid, Caprylyl Glycol, Allantoin, Tocopheryl Acetate, Iron Oxide (CI 77492), Iron Oxide (CI 77491), Iron Oxide (CI 77499), Triethoxycaprylylsilane, Talc, BHT, Disodium EDTA, Fragrance

PURPOSE

OTC - PURPOSE SECTION

Purpose: Sunscreen

WARNINGS

WARNINGS SECTION

Warnings: 1. If the following side effects occur, immediately discontinue use. Before resuming use, consult a dermatologist as continual use may worsen symptoms. A) If red spots, swelling, itching, irritation, or other discomforts occur after using the product. B) If the above symptoms occur on the applied area after exposure to direct sunlight. 2. Do not use on open wounds or on areas of skin exhibiting signs of eczema or dermatitis. 3. Storage and handling precautions A) Keep product out of reach of infants and children. B) Ensure that lid is closed after use. C) Do not store in places subject to high or cold temperatures or under exposure to direct sunlight. D) Use care to avoid eye contact when using this product.

DESCRIPTION

DESCRIPTION SECTION

Indications & Usage: 1. Shake before using, apply evenly to clean face after skin care and treatment serum. 2. Tap applied face softly for better absorption. 3. Always replace cap after use

Dosage & Administration: Apply appropriate amount onto face after applying activator or cleansing.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of cartonImage of carton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70619-010-012021-01-29C16284748780-1ba0f9c33-54e6-a910-e053-dadaa90a0b85392fc83e-eeb1-49de-8c40-7c2ea0c1d2e5

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70619-010-01BR Waterfull BB BLEMISH BALM BRIGHT40 g in 1 CARTONCREAM401

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70619-010BR WATERFULL BB BLEMISH BALM BRIGHT (TITANIUM DIOXIDE, OCTINOXATE) CREAM [BR]1Legacy NDC, 1 package rows20160418_392fc83e-eeb1-49de-8c40-7c2ea0c1d2e5.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
70619-01070619-010-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
365b21dd-d803-463a-b0dc-f8fd81e0bb5d392fc83e-eeb1-49de-8c40-7c2ea0c1d2e52016-04-18WarningsExact identifier
spl id: 365b21dd-d803-463a-b0dc-f8fd81e0bb5d
spl set id: 392fc83e-eeb1-49de-8c40-7c2ea0c1d2e5

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.